Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpura

Lancet

Volumn 352, Issue 9126, 1998, Pages 454-455

  Raife, Thomas J ^a   McArthur, Jennifer ^b   Peters, Charles ^b   Kisker, C Thomas ^b   Lentz, Steven R ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN; ISOTRETINOIN; METHYLPREDNISOLONE; RETINOIC ACID;

ARTICLE; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032497150     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79189-3     Document Type: Article

References (5)

1. 1 Bukowski RM. Thrombotic thrombocytopenic purpura: a review. Prog Hemost Thromb 1982; 6: 287-37.
2. 2 Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombocytopenic purpura. Eur J Haematol 1996; 56: 191-207.
3. 3 Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, eds. The retinoids: biology, chemistry, and medicine, 2nd edn. New York: Raven Press, 1994: 443-520.
4. 4 Ishii H, Horie S, Kizaki K, Kazami M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 1992; 80: 2556.
5. 5 Barbui T, Finazzi G, Falanga A. The impact of all-trans retinoic acid on the coagulopathy of acute promyelocytic leukaemia. Blood 1998: 91: 3093-102.